- KR₩421bn
- -KR₩141m
- KR₩90bn
- 56
- 49
- 24
- 35
Annual cashflow statement for Bionote, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | — | 528,229 | 671,556 | 307,798 | -20,497 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | — | 31,361 | -169,607 | 8,799 | 25,284 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 9,851 | -321,551 | 31,336 | -73,948 | -17,187 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 9,851 | 239,926 | 537,392 | 249,100 | -4,194 |
| Capital Expenditures | -1,528 | -26,722 | -51,544 | -42,484 | -4,542 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -32,364 | -84,671 | -139,839 | 11,953 | -477,013 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -33,893 | -111,393 | -191,383 | -30,530 | -481,555 |
| Financing Cash Flow Items | — | 415 | -50,379 | 50 | -39.5 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 26,752 | -11,665 | -50,596 | 22,955 | -49,901 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2,634 | 116,504 | 295,532 | 262,455 | -533,672 |